SciELO - Scientific Electronic Library Online

 
vol.75 número3Contaminação viral durante cirurgias sequenciais de facoemulsificação em um modelo experimentalCorrelação entre a espessura do subcampo central, a acuidade visual e mudanças estruturais no edema macular diabético índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Arquivos Brasileiros de Oftalmologia

versão impressa ISSN 0004-2749

Resumo

FADLALLAH, Ali et al. Azithromycin 1.5% ophthalmic solution: efficacy and treatment modalities in chronic blepharitis. Arq. Bras. Oftalmol. [online]. 2012, vol.75, n.3, pp.178-182. ISSN 0004-2749.  http://dx.doi.org/10.1590/S0004-27492012000300006.

PURPOSE: To assess the efficacy of topical 1.5% azithromycin in the treatment of moderate to severe chronic blepharitis and to compare the efficacy of two different treatment modalities. METHODS: A randomized clinical trial included 67 patients with chronic anterior and/or posterior blepharitis, followed-up for 3 months. Signs and symptoms were graded according to severity. Patients were randomized into two groups: 33 patients in group I and 34 patients in group II. Group I patients were treated with topical 1.5% azithromycin twice a day for three days, and Group II patients were treated with topical 1.5% azithromycin twice a day for three days then at bedtime for the rest of the month. All patients were instructed to apply warm compresses and an eye-friendly soap twice daily. RESULTS: Patients in both groups tolerated the treatment with minimal irritation. A significant improvement in signs and symptoms was noted at the one week follow-up visit. Group II showed a more pronounced and longer-lasting improvement that persisted after three months of follow-up. CONCLUSION: Topical 1.5% azithromycin ophthalmic solution is an effective treatment option for chronic blepharitis. In moderate to severe blepharitis, a one month treatment is safe and shows better improvement than the three-day protocol with no significant relapse until three months of follow-up.

Palavras-chave : Azithromycin [administration & dosage]; Blepharitis [drug therapy]; Chronic disease; Ophthalmic solutions; Meibomian glands.

        · resumo em Português     · texto em Inglês     · Inglês ( pdf epdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons